These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38916974)

  • 21. Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.
    Harrison D; Muskett H; Harvey S; Grieve R; Shahin J; Patel K; Sadique Z; Allen E; Dybowski R; Jit M; Edgeworth J; Kibbler C; Barnes R; Soni N; Rowan K
    Health Technol Assess; 2013 Feb; 17(3):1-156. PubMed ID: 23369845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiological characteristics and risk factors of sepsis development and death in patients with extremely severe burns].
    Pan XL; Zhu ZK; Shen T; Jin F; Wang XG; Yin J; Han CM
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):558-564. PubMed ID: 37805772
    [No Abstract]   [Full Text] [Related]  

  • 23. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center.
    Linke C; Tragiannidis A; Ahlmann M; Fröhlich B; Wältermann M; Burkhardt B; Rossig C; Groll AH
    Mycoses; 2019 Oct; 62(10):954-960. PubMed ID: 31332851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA
    Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
    Kuster S; Stampf S; Gerber B; Baettig V; Weisser M; Gerull S; Medinger M; Passweg J; Schanz U; Garzoni C; Berger C; Chalandon Y; Mueller NJ; van Delden C; Neofytos D; Khanna N;
    Transpl Infect Dis; 2018 Dec; 20(6):e12981. PubMed ID: 30144374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with acute kidney injury in the Helsinki Burn Centre in 2006-2015.
    Rakkolainen I; Lindbohm JV; Vuola J
    Scand J Trauma Resusc Emerg Med; 2018 Dec; 26(1):105. PubMed ID: 30545389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
    Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revised Baux Score and updated Charlson comorbidity index are independently associated with mortality in burns intensive care patients.
    Heng JS; Clancy O; Atkins J; Leon-Villapalos J; Williams AJ; Keays R; Hayes M; Takata M; Jones I; Vizcaychipi MP
    Burns; 2015 Nov; 41(7):1420-7. PubMed ID: 26187055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
    Rodríguez-Veiga R; Montesinos P; Boluda B; Lorenzo I; Martínez-Cuadrón D; Salavert M; Pemán J; Calvillo P; Cano I; Acuña E; Villalba A; Piñana JL; Sanz J; Solves P; Senent L; Vicente A; Sempere A; Cervera J; Barragán E; Jarque I; Torres A; Sanz MA; Sanz GF
    Ann Hematol; 2019 Sep; 98(9):2081-2088. PubMed ID: 31240471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of risk factors for bloodstream infections in patients with major burns receiving intensive care: A retrospective single-center cohort study.
    Fochtmann-Frana A; Freystätter C; Vorstandlechner V; Barth A; Bolliger M; Presterl E; Ihra G; Muschitz G; Mittlboeck M; Makristathis A; Rath T; Radtke C; Forstner C
    Burns; 2018 Jun; 44(4):784-792. PubMed ID: 29395408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiological findings in burn patients treated in a general versus a designated intensive care unit: Effect on length of stay.
    Issler-Fisher AC; Fakin RM; Fisher OM; McKew G; Gazzola R; Rauch AK; Gottlieb T; Haertsch P; Guggenheim M; Giovanoli P; Maitz PK
    Burns; 2016 Dec; 42(8):1805-1818. PubMed ID: 27372144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-state evaluation of Candida infections in burn patients.
    Salimi M; Javidnia J; Abastabar M; Mobayen MR; Moslemi A; Rahimzadeh G; Yazdani Charati J; Mirzaei Tirabadi N; Nouranibaladezaei S; Asghari H; Sobouti B; Dahmardehei M; Seyedmousavi S; Shokohi T
    Mycoses; 2024 Aug; 67(8):e13788. PubMed ID: 39166776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of clinical characteristics and risk factors of death in critical burn patients complicated with invasive fungal infection].
    Li YG; Chang SL; Xie JF; Ye XY; Wang L; Li YC; Li Y; Li XL
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jul; 39(7):618-624. PubMed ID: 37805690
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical characteristics and risk factors for severe burns complicated by early acute kidney injury.
    Chen B; Zhao J; Zhang Z; Li G; Jiang H; Huang Y; Li X
    Burns; 2020 Aug; 46(5):1100-1106. PubMed ID: 31839503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients.
    Rodríguez-Veiga R; Montesinos P; García E; Boluda B; Rojas R; Serrano J; Martínez-Cuadrón D; Martín C; Sanz J; Tabares S; Piñana JL; Lorenzo I; Montoro J; Salavert M; Pemán J; Jarque I; Solves P; Sanz GF; Torres A; Sanz MA
    Mycoses; 2019 May; 62(5):418-427. PubMed ID: 30633829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classification of invasive fungal disease in patients with acute myeloid leukaemia.
    Rieger CT; Huppmann S; Peterson L; Rieger H; Ostermann H
    Mycoses; 2011 Jul; 54(4):e92-8. PubMed ID: 20202112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Empirical antifungal treatment for diagnosed and undiagnosed invasive fungal disease in patients with hematologic malignancies.
    Deng Q; Lv HR; Lin XM; Zhao MF; Geng L; Li YM
    Curr Med Res Opin; 2018 Jul; 34(7):1209-1216. PubMed ID: 28956459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of Targeted Fungal Sequencing for Culture-Independent Diagnosis of Invasive Fungal Disease.
    Gomez CA; Budvytiene I; Zemek AJ; Banaei N
    Clin Infect Dis; 2017 Nov; 65(12):2035-2041. PubMed ID: 29020284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of mobility training on severe burn patients in the BICU: A retrospective cohort study.
    Deng H; Chen J; Li F; Li-Tsang CW; Liu Q; Ma X; Ao M; Chen N; Zhou Y; Zhong X; Chen Z; Cao L; He G; Wu J
    Burns; 2016 Nov; 42(7):1404-1412. PubMed ID: 27595451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of Invasive Fungal Disease in Children.
    Pana ZD; Roilides E; Warris A; Groll AH; Zaoutis T
    J Pediatric Infect Dis Soc; 2017 Sep; 6(suppl_1):S3-S11. PubMed ID: 28927200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.